MCP
BCLI

Mirador Capital Partners’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Mirador Capital Partners’s Portfolio BCLI Stock Details BCLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,768
Closed -$5.31K – 184
2023
Q3 		$5.31K Buy
1,768
+96
+6% +$288 ﹤0.01% 184
2023
Q2 		$51.7K Buy
+1,672
New +$51.7K 0.01% 186